TALIANI, GLORIA
 Distribuzione geografica
Continente #
NA - Nord America 1.385
EU - Europa 543
AS - Asia 142
AF - Africa 3
Totale 2.073
Nazione #
US - Stati Uniti d'America 1.380
GB - Regno Unito 172
IT - Italia 114
DE - Germania 92
SE - Svezia 69
SG - Singapore 54
CN - Cina 35
UA - Ucraina 29
TR - Turchia 20
HK - Hong Kong 19
FI - Finlandia 18
BE - Belgio 11
FR - Francia 11
BG - Bulgaria 10
ID - Indonesia 6
CA - Canada 3
ET - Etiopia 3
IN - India 3
PL - Polonia 3
RU - Federazione Russa 3
AL - Albania 2
AT - Austria 2
BZ - Belize 2
CZ - Repubblica Ceca 2
IL - Israele 2
JP - Giappone 2
LT - Lituania 2
AM - Armenia 1
CH - Svizzera 1
NL - Olanda 1
RO - Romania 1
Totale 2.073
Città #
Fairfield 225
Southend 148
Santa Clara 120
Ashburn 118
Chandler 117
Seattle 100
Woodbridge 96
Houston 81
Wilmington 72
Modena 68
Cambridge 62
Ann Arbor 61
Dearborn 57
Nyköping 52
Singapore 49
Jacksonville 44
Hong Kong 19
Izmir 19
New York 19
Helsinki 18
San Diego 16
Brussels 11
Grafing 11
Eugene 10
Princeton 10
Sofia 10
Bremen 9
Munich 8
Redwood City 7
Leawood 6
Jakarta 5
Rome 5
Beijing 4
London 4
Addis Ababa 3
Boardman 3
Dallas 3
Falkenstein 3
Monmouth Junction 3
Mumbai 3
Naples 3
San Mateo 3
Shanghai 3
Belize City 2
Chicago 2
Fremont 2
Kilburn 2
Los Angeles 2
Pozzo 2
Turin 2
Vienna 2
Amsterdam 1
Ankara 1
Atlanta 1
Brno 1
Calcinaia 1
Chiswick 1
Cilacap 1
Cividale Del Friuli 1
Falls Church 1
Indiana 1
Islington 1
Jinan 1
Kunming 1
Lanzhou 1
Maimatsubara 1
Markham 1
Milan 1
Modesto 1
Montréal 1
Mountain View 1
Nanchang 1
Napoli 1
Novokuznetsk 1
Olomouc 1
Ottawa 1
Polesella 1
Rho 1
Shenyang 1
Tel Aviv 1
Warsaw 1
Yerevan 1
Zurich 1
Totale 1.736
Nome #
Liver Angiopoietin-2 is a key predictor of de novo or recurrent hepatocellular cancer after HCV direct-acting antivirals 317
Treatment of Hepatitis C virus infection in Italy: A consensus report from an expert panel 290
Premature ovarian senescence and a high miscarriage rate impair fertility in women with HCV 214
Multiclass HCV resistance to direct-acting antiviral failure in real-life patients advocates for tailored second-line therapies 211
Modeling cost-effectiveness and health gains of a “universal” versus “prioritized” hepatitis C virus treatment policy in a real-life cohort 206
AISF position paper on liver transplantation and pregnancy: Women in Hepatology Group, Italian Association for the Study of the Liver (AISF) 188
From current status to optimization of HCV treatment: Recommendations from an expert panel 176
Corrigendum to “Premature ovarian senescence and a high miscarriage rate impair fertility in women with HCV” [J Hepatol 68 (2018) 33–41](S0168827817322596)(10.1016/j.jhep.2017.08.019) 175
Current and future challenges in HCV: insights from an Italian experts panel 167
Incidence of DAA failure and the clinical impact of retreatment in real-life patients treated in the advanced stage of liver disease: Interim evaluations from the PITER network 157
Totale 2.101
Categoria #
all - tutte 7.849
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 7.849


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020281 0 0 0 0 0 83 70 37 44 16 24 7
2020/2021525 31 7 26 55 66 46 122 34 30 59 38 11
2021/2022283 31 21 7 22 7 25 18 27 25 18 51 31
2022/2023279 44 38 30 33 27 31 9 26 19 1 11 10
2023/2024141 5 8 11 13 14 20 14 12 6 0 13 25
2024/2025200 13 0 6 46 86 49 0 0 0 0 0 0
Totale 2.101